PNC Financial Services Group’s Alexion Pharmaceuticals ALXN Stock Holding History

PNC Financial Services Group’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21,445	Closed	-$3.94M	–	4512
2021 Q2	$3.94M	Buy	21,445 +178	+0.8%	+$30.6K	﹤0.01%	717
2021 Q1	$3.25M	Sell	21,267 -1,123	-5%	-$174K	﹤0.01%	730
2020 Q4	$3.5M	Buy	22,390 +1,105	+5%	+$142K	﹤0.01%	696
2020 Q3	$2.44M	Sell	21,285 -1,012	-5%	-$109K	﹤0.01%	750
2020 Q2	$2.5M	Buy	22,297 +311	+1%	+$33K	﹤0.01%	734
2020 Q1	$1.98M	Sell	21,986 -1,452	-6%	-$143K	﹤0.01%	737
2019 Q4	$2.54M	Sell	23,438 -30,422	-56%	-$3.25M	﹤0.01%	748
2019 Q3	$5.28M	Sell	53,860 -303,792	-85%	-$34.2M	0.01%	651
2019 Q2	$46.8M	Sell	357,652 -29,269	-8%	-$3.77M	0.05%	245
2019 Q1	$52.3M	Buy	386,921 +350,645	+967%	+$43.6M	0.05%	228
2018 Q4	$3.53M	Sell	36,276 -2,167	-6%	-$256K	﹤0.01%	799
2018 Q3	$5.34M	Sell	38,443 -5,916	-13%	-$742K	0.01%	744
2018 Q2	$5.51M	Sell	44,359 -1,349	-3%	-$158K	0.01%	721
2018 Q1	$5.09M	Sell	45,708 -3,851	-8%	-$460K	0.01%	727
2017 Q4	$5.93M	Sell	49,559 -3,458	-7%	-$421K	0.01%	672
2017 Q3	$7.44M	Sell	53,017 -4,007	-7%	-$544K	0.01%	574
2017 Q2	$6.94M	Buy	57,024 +6,381	+13%	+$743K	0.01%	588
2017 Q1	$6.14M	Buy	50,643 +1,285	+3%	+$166K	0.01%	616
2016 Q4	$6.04M	Sell	49,358 -185	-0.4%	-$22.6K	0.01%	619
2016 Q3	$6.07M	Buy	49,543 +2,647	+6%	+$341K	0.01%	612
2016 Q2	$5.47M	Sell	46,896 -2,586	-5%	-$367K	0.01%	614
2016 Q1	$6.89M	Buy	49,482 +4,360	+10%	+$640K	0.01%	568
2015 Q4	$8.61M	Sell	45,122 -10,896	-19%	-$1.9M	0.01%	517
2015 Q3	$8.76M	Buy	56,018 +2,062	+4%	+$376K	0.01%	518
2015 Q2	$9.75M	Buy	53,956 +10,632	+25%	+$1.83M	0.01%	519
2015 Q1	$7.51M	Buy	43,324 +1,916	+5%	+$347K	0.01%	592
2014 Q4	$7.66M	Buy	41,408 +750	+2%	+$139K	0.01%	570
2014 Q3	$6.74M	Buy	40,658 +3,282	+9%	+$539K	0.01%	580
2014 Q2	$5.84M	Sell	37,376 -1,329	-3%	-$210K	0.01%	593
2014 Q1	$5.89M	Sell	38,705 -10,298	-21%	-$1.64M	0.01%	571
2013 Q4	$6.51M	Sell	49,003 -3,149	-6%	-$378K	0.01%	552
2013 Q3	$6.06M	Sell	52,152 -5,184	-9%	-$569K	0.01%	545
2013 Q2	$5.29M	Buy	+57,336	New	+$5.53M	0.01%	549

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return